Αποτελέσματα Αναζήτησης
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
27 Ιουλ 2023 · NNRTIs like nevirapine (Viramune) are the most common cause of medication skin rashes. Abacavir (Ziagen) is an NRTI drug that can cause skin rashes.
With increased survival and improved overall health, PLHIV are experiencing dermatologic issues both specific to HIV and common to the general population. In this new era of ART, it is crucial for dermatologists to have a strong understanding of the broad range of cutaneous disease and treatment options in this unique population.
26 Φεβ 2019 · In this review, we outline the most common skin diseases in PLHIV, including HIV-associated malignancies, inflammatory conditions, and infections, and focus on the role of ART in altering epidemiology, clinical features, diagnosis, and treatment of cutaneous conditions.
4 Σεπ 2024 · If you think you have been exposed to HIV and developed a rash, see your health care provider immediately. HIV medicines can help restore the immune system and reduce viral load, leading to significant improvement in HIV-related skin conditions. If your rash is caused by an HIV medicine, switching to another medicine should help the rash go away.
29 Μαρ 2024 · The defect in cell-mediated immunity that results from HIV infection predisposes infected individuals to certain bacterial, fungal, mycobacterial, parasitic, and viral infections, many of which have skin manifestations.
23 Δεκ 2021 · BEAUBIEN: Cabotegravir is the first injectable form of HIV pre-exposure prophylaxis, a treatment also known as PrEP. Up until now, PrEP was available only in an oral form in which pills had to...
